FindTrial
Sign In

Can shear wave elastography be used in patients with NASH ?

Role of shear wave elastography in Non Alcoholic Steatohepatitis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/09/036794
Enrollment
30
Registered
2021-09-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified

Interventions

None listed

Sponsors

Pt bd Sharma Pgims Rohtak
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinically and biopsy proven cases of Non alcoholic steatohepatitis

Exclusion criteria

Exclusion criteria: 1) positive results for hepatitis B surface antigen (HBsAg), anti-hepatitis C virus (anti- HCV), and anti-mitochondrial antibody 2) suspicious drug usage, alcohol abuse, hereditary diseases nor any other clinical manifestations causing liver cell damage 3) surgical procedures and total parenteral nutrition

Design outcomes

Primary

MeasureTime frame
Sensitivity of shear wave elastography as a tool for NASHTimepoint: 1 year—

Secondary

MeasureTime frame
To evaluate role of shear wave elastography in NASHTimepoint: 1 year—

Countries

India

Contacts

Public ContactDr Lovleen

Pt BD Sharma PGIMS Rohtak

jyotsnasen29@gmail.com8168496744

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026